Nureca: Promoter Group Entity Exits Entire 0.63% Stake via Off-Market Sale

Ownership Changes View source PDF Explain this filing

NURECA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.6%Reaction day

₹234.10

prior close

₹232.20

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.4%-1.1% vs market

Medical Equipment & Supplies peers, median of 12sector+0.2%-2.8% vs sector

On the reaction day the stock moved 1.1 pts less than Nifty Microcap 250 and 2.8 pts less than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.9

10m

+0.4

15m

+0.4

30m

+1.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.6-1.4-1.1+0.2-2.8

Next day

-1.7-2.5+0.8+0.0-1.7

-0.9+0.4-1.3+1.3-2.2

+0.6+2.2-1.5+1.6-1.0

+1.2+2.7-1.5+5.6-4.3

+1.7+3.9-2.2+6.6-4.9

+2.1+5.2-3.1+6.7-4.6

15d

+0.4+6.5-6.1+7.5-7.1

-0.0+6.9-6.9+8.1-8.1

+47.4+9.1+38.2+3.1+44.3

+46.3+11.6+34.7+8.9+37.4

UpDownMarket · Nifty Microcap 250Sector · Medical Equipment & Supplies peers, median of 12Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Nectar Biopharma, a Nureca promoter group entity, sold its entire 60,842 shares (0.63% stake) for about Rs. 14.37 crore via an off-market deal on June 9, 2026. After the sale, the entity holds zero shares. The disclosure was filed under SEBI insider trading norms.

Likely market impact

Promoter group entity exits fully, may signal mild negative sentiment but stake was small at 0.63%.